Exact Sciences Corporation (NASDAQ:EXAS) in last trading activity fell -1.36% to close at $21.72. Company weekly performance is -5.81% while its quarterly performance stands at -23.87%. Exact Sciences Corporation (NASDAQ:EXAS) is -27.53% away from its 52 week high. On March 30, Exact Sciences Corp. (NASDAQ:EXAS) announced that Tufts Health Plan, with more than 1 million members across Massachusetts and Rhode Island, will cover Cologuard as a colon cancer screening test effective March 15, 2015.
On Wednesday shares of Toyota Motor Corporation (NYSE:TM) closed at $138.48. Company’s sales growth for last 5 years was 4.60% and EPS growth for next 5 years is recorded as 33.70%. Toyota Motor Corp. (NYSE:TM) Wednesday said its U.S. sales for March increased 4.9 percent, as strong marketing and cheap oil prices helped the Japanese automaker lure more customers. Toyota’s U.S. sales in March increased 4.9 percent to 225,959 units from 215,348 units a year ago. Sales rose an 8.5 percent on a daily selling rate basis. The month had one less selling day.
Boston Scientific Corporation (NYSE:BSX) in last trading activity decreased -0.56% to close at $17.65. Company weekly performance is 0.74% while its quarterly performance stands at 32.01%. Boston Scientific Corporation (NYSE:BSX) is -2.86% away from its 52 week high. Boston Scientific Corporation (NYSE:BSX) announces that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device company that develops, manufactures and sells minimally invasive devices for Endoscopic Ultrasound (EUS) guided transluminal drainage of targeted areas within the gastrointestinal tract. The deal is expected to close this week.
On last trading day PPG Industries Inc. (NYSE:PPG) decreased -0.48% to close at $224.46. Its volatility for the week is 1.47% while volatility for the month is 1.60%. PPG’s sales growth for past 5 years was 4.60% and its EPS growth for past 5 years was 31.10%. PPG Industries Inc. (NYSE:PPG) monthly performance is -4.30%. PPG Industries (NYSE:PPG) announced that it has completed the acquisition of REVOCOAT, a global supplier of sealants, adhesives and damper products for the automotive industry, from the AXSON Group. Financial terms were not disclosed.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has 2.30% insider ownership while its institutional ownership stands at 66.80%. In last trading activity company’s stock closed at $197.39. Canadian drug maker Valeant Pharmaceuticals International Inc (NYSE:VRX) on Wednesday said it has closed its about $11 billion acquisition of gastrointestinal drug maker Salix Pharmaceuticals Ltd. Valeant offered a sweetened $173 per Salix share, or about $11.1 billion, to clinch the merger. Including debt, the deal is valued at $15.8 billion.